NCT01949714

Brief Summary

  • To investigate the effect of catecholamine excess on brown fat.
  • To evaluate the effect of brown fat on energy expenditure and lipid and glucose metabolism

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 24, 2013

Completed
8.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

May 23, 2022

Status Verified

May 1, 2022

Enrollment Period

8.4 years

First QC Date

September 20, 2013

Last Update Submit

May 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • [18F]FDG uptake in brown adipose tissue

    3 months

Study Arms (1)

Pheochromocytoma patients

Pheochromocytoma patients

Procedure: Removal of adrenal tumor

Interventions

Pheochromocytoma patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with adrenal tumors

You may qualify if:

  • patients with pheochromocytoma
  • patients with incidentaloma without hormone production
  • Age \> 18 years

You may not qualify if:

  • \- None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology MEA, Aarhus Hospital

Aarhus C, Please Select, 8000, Denmark

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood and adipose tissue samples

MeSH Terms

Conditions

PheochromocytomaAdrenal incidentaloma

Condition Hierarchy (Ancestors)

ParagangliomaNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Nerve Tissue

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Post Doc

Study Record Dates

First Submitted

September 20, 2013

First Posted

September 24, 2013

Study Start

August 1, 2013

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

May 23, 2022

Record last verified: 2022-05

Locations